New Market Study Published: Sickle Cell Disease - Pipeline Review, H2 2012
Global Markets Direct's, 'Sickle Cell Disease - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Sickle Cell Disease, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Sickle Cell Disease. Sickle Cell Disease - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites,...
View full press release